Literature DB >> 23548945

Osthole ameliorates renal ischemia-reperfusion injury by inhibiting inflammatory response.

Yi Zheng1, Min Lu, Lulin Ma, Shudong Zhang, Min Qiu, Xin Ma.   

Abstract

INTRODUCTION: Renal ischemia-reperfusion (I/R) injury is a primary cause of acute renal failure that results in high mortality. This study aimed to investigate the effect of osthole, a natural coumarin derivative, on renal I/R injury in a rat model.
MATERIALS AND METHODS: Rats were randomly allocated to the sham operation + vehicle, I/R + vehicle, and I/R + osthole groups. Renal I/R injury was induced by clamping the left renal artery for 45 min followed by 12 h of reperfusion and a contralateral nephrectomy. Osthole (40 mg/kg) was intraperitoneally injected 30 min before inducing I/R. Renal function and histological damage were determined subsequently. Myeloperoxidase activity, monocyte/macrophage infiltration, as well as tumor necrosis factor-α, IL-1β, and activated p38 mitogen-activated protein kinase expression in kidneys were also assessed.
RESULTS: Osthole treatment significantly ameliorated I/R-induced renal functional and morphological injuries. Moreover, osthole treatment attenuated myeloperoxidase activity, monocyte/macrophage infiltration, and tumor necrosis factor-α, IL-1β, and activated p38 mitogen-activated protein kinase expression in kidneys.
CONCLUSIONS: Osthole treatment ameliorates renal I/R injury by inhibiting inflammatory responses in kidneys. Thus, osthole may represent a novel practical strategy to prevent renal I/R injury.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23548945     DOI: 10.1159/000347191

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  6 in total

1.  Inhibition of osteolysis after local administration of osthole in a TCP particles-induced osteolysis model.

Authors:  Shumin Lv; Yun Zhang; Ming Yan; Hongjiao Mao; Cailing Pan; Mingxiao Gan; Jiawen Fan; Guoxia Wang
Journal:  Int Orthop       Date:  2015-10-26       Impact factor: 3.075

2.  Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway.

Authors:  Kuo-Feng Hua; Shun-Min Yang; Tzu-Yang Kao; Jia-Ming Chang; Hui-Ling Chen; Yung-Jen Tsai; Ann Chen; Sung-Sen Yang; Louis Kuoping Chao; Shuk-Man Ka
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

3.  Osthole Ameliorates Renal Fibrosis in Mice by Suppressing Fibroblast Activation and Epithelial-Mesenchymal Transition.

Authors:  Suping Zhang; Qian Huang; Xiaoxia Cai; Shan Jiang; Nan Xu; Qin Zhou; Xiaoyun Cao; Michael Hultström; Jiong Tian; En Yin Lai
Journal:  Front Physiol       Date:  2018-11-21       Impact factor: 4.566

4.  MicroRNA-579-3p Exerts Neuroprotective Effects Against Ischemic Stroke via Anti-Inflammation and Anti-Apoptosis.

Authors:  Jiaoying Jia; Yan Cui; Zhigang Tan; Wenjia Ma; Yugang Jiang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-12       Impact factor: 2.570

5.  Osthol Ameliorates Kidney Damage and Metabolic Syndrome Induced by a High-Fat/High-Sugar Diet.

Authors:  Fernando E García-Arroyo; Guillermo Gonzaga-Sánchez; Edilia Tapia; Itzel Muñoz-Jiménez; Lino Manterola-Romero; Horacio Osorio-Alonso; Abraham S Arellano-Buendía; José Pedraza-Chaverri; Carlos A Roncal-Jiménez; Miguel A Lanaspa; Richard J Johnson; Laura Gabriela Sánchez-Lozada
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

6.  Osthole decreases renal ischemia-reperfusion injury by suppressing JAK2/STAT3 signaling activation.

Authors:  Lin-Na Luo; De Qiong Xie; Xiao Gang Zhang; Rong Jiang
Journal:  Exp Ther Med       Date:  2016-08-22       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.